» Authors » Outi Kuittinen

Outi Kuittinen

Explore the profile of Outi Kuittinen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 92
Citations 1272
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Anttalainen A, Ukkola-Vuoti L, Vihervaara V, Silvola S, Kuittinen O
Acta Oncol . 2025 Feb; 64:303-311. PMID: 39996583
Background: Large B-cell lymphomas (LBCLs) form a notable subgroup of lymphomas; however, their associated long-term comorbidities and mortality rates remain under-researched in real-world settings. Material And Methods: This nationwide Finnish...
2.
Antikainen T, Hannuksela N, Anttalainen A, Partanen A, Ronka A, Kuitunen H, et al.
Eur J Public Health . 2025 Jan; PMID: 39833131
Hodgkin's lymphoma (HL) is a lymphoid malignancy with an emphasized incidence in developed countries. This study aimed to assess the changes in the epidemiology of HL in Finland at the...
3.
Hayrinen M, Kiiskila J, Ranki A, Vakeva L, Barton H, Kuusisto M, et al.
Cancers (Basel) . 2025 Jan; 17(1. PMID: 39796791
In the original publication [...].
4.
Pellonpera E, Puhakka I, Kuitunen H, Ronka A, Sunela K, Kuusisto M, et al.
Eur J Haematol . 2025 Jan; PMID: 39789609
Purpose: The prognosis of relapsed primary central nervous system lymphoma remains a concern. This study aimed to compare the effects of various patient- and disease-related factors on the prognosis of...
5.
Harmanen M, Hujo M, Sund R, Sorigue M, Khan M, Prusila R, et al.
Hematol Oncol . 2025 Jan; 43(1):e70024. PMID: 39775920
Mantle cell lymphoma is a rare type of B-cell lymphoma, which is considered incurable yet treatable. In recent years, the treatment options of mantle cell lymphoma have multiplied, and the...
6.
Kotkaranta P, Chan M, Vuolio T, Miinalainen I, Kuitunen H, Turpeenniemi-Hujanen T, et al.
Biomed Pharmacother . 2024 Dec; 182():117785. PMID: 39721323
It has been demonstrated that diffuse large B-cell lymphoma (DLBCL) is especially sensitive to ferroptosis. Currently, confirming the presence of ferroptosis requires flow cytometry, which is a time consuming and...
7.
Handelin J, Teppo H, Haapasaari K, Ollikainen R, Kemppainen J, Kuitunen H, et al.
Anticancer Res . 2024 Oct; 44(11):4961-4967. PMID: 39477316
Background/aim: Testicular cancers, particularly seminomas and non-seminomas, generally have a favorable prognosis, although a small subset of patients experience mortality. Current knowledge of clinical markers associated with relapse and poor...
8.
Hayrinen M, Teppo H, Vakeva L, Ranki A, Barton H, Porvari K, et al.
J Invest Dermatol . 2024 Sep; 145(3):700-703.e5. PMID: 39245139
No abstract available.
9.
Hannuksela N, Partanen A, Anttalainen A, Ukkola-Vuoti L, Toppila I, Vikkula J, et al.
Blood Cancer J . 2024 Aug; 14(1):139. PMID: 39164236
No abstract available.
10.
Partanen A, Turunen A, Kuittinen O, Kuitunen H, Mantymaa P, Varmavuo V, et al.
Cancers (Basel) . 2024 Jul; 16(14). PMID: 39061190
Early lymphocyte recovery as manifested by an absolute lymphocyte count at d+15 (ALC-15) ≥ 0.5 × 10/L after autologous hematopoietic stem cell transplantation (AHCT) has been associated with a better...